Factors Associated with Chronic Obstructive Pulmonary Disease: A Hospital-Based Case–Control Study

References

• Hogea SP, Tudorache E, Fildan AP, Fira-Mladinescu O, Marc M, Oancea C. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J. 2020;14(3):183–197. PMID: 31814260. doi:10.1111/drj.13129
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010, 182(5):693–718. doi:10.1164/rccm.200811-1757ST
   PubMed Web of Science ®Google Scholar
• Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2008;3(4):693–699. doi:10.2147/copd.s948
   PubMedGoogle Scholar
• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):ITC17–ITC32. PMID:32745458. doi:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. PMID: 28128970. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Weissmann N. Chronic obstructive pulmonary disease and pulmonary vascular disease. A comorbidity? Ann Am Thorac Soc. 2018;15(Suppl 4):S278–S281. PMID: 30759003; PMCID: PMC6944394. doi:10.1513/AnnalsATS.201808-532MG
   PubMedGoogle Scholar
• GBD 2019 Disease and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Salvi SS, Manap R, Beasley R. Understanding the true burden of COPD: the epidemiological challenges. Prim Care Respir J. 2012;21(3):249–251. PMID: 22885564; PMCID: PMC6547972. doi:10.4104/pcrj.2012.00082
   PubMedGoogle Scholar
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-2
   PubMed Web of Science ®Google Scholar
• Awokola BI, Amusa GA, Jewell CP, et al. Chronic obstructive pulmonary disease in sub-Saharan Africa. Int J Tuberc Lung Dis. 2022;26(3):232–242. PMID: 35197163; PMCID: PMC8886964. doi:10.5588/ijtld.21.0394
   PubMed Web of Science ®Google Scholar
• Capistrano S, van Reyk D, Chen H and Oliver B. Evidence of Biomass Smoke Exposure as a Causative Factor for the Development of COPD. Toxics. 2017;5(4):36. doi: 10.3390/toxics5040036
   PubMed Web of Science ®Google Scholar
• Burney P, Patel J, Minelli C, et al. Prevalence and population attributable risk for chronic airflow obstruction in a large multinational study. Am J Respir Crit Care Med. 2020;203(11):1353–1365. doi:10.1164/rccm.202005-1990OC
   Web of Science ®Google Scholar
• Van Gemert F, Kirenga B, Chavannes N, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3(1):e44–e51. PMID: 25539969. doi:10.1016/S2214-109X(14)70337-7
   PubMed Web of Science ®Google Scholar
• Pellegrino R. Interpretative strategies for lung function tests. European Respiratory Journal. 2005;26(5): 948–968. doi:10.1183/09031936.05.00035205
   PubMed Web of Science ®Google Scholar
• Meghwani MK, Tiwari HC, Mishra R and Kumar S. Chronic Obstructive Pulmonary Disease and Its Risk Factors: A Case Control Study. JEMDS. 2013;2(34):6382–6386. doi:10.14260/jemds/1148
   Google Scholar
• Njoroge MW et al . Changing lung function and associated health-related quality-of-life: A five-year cohort study of Malawian adults. eClinicalMedicine. 2021;41:101166. doi: 10.1016/j.eclinm.2021.101166
   PubMedGoogle Scholar
• Musafiri S, Joos G, Van Meerbeeck JP. Asthma, atopy and COPD in sub-Saharan countries: the challenges. East Afr J Public Health. 2011;8(2):161–163. PMID: 22066305.
   PubMedGoogle Scholar
• Fattahi F, ten Hacken NH, Löfdahl CG, et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir Res. 2013;14(1):10. PMID: 23356508; PMCID: PMC3599617. doi:10.1186/1465-9921-14-10
   PubMedGoogle Scholar
• Jamieson DB, Matsui A, Belli MC, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(2):187–192. doi:10.1164/rccm.201211-2103OC
   PubMed Web of Science ®Google Scholar
• North CM, Allen JG, Okello S, et al. HIV infection, pulmonary tuberculosis, and COPD in Rural Uganda: a cross-sectional study. Lung. 2018;196(1):49–57. PMID: 29260309; PMCID: PMC6261662. doi:10.1007/s00408-017-0080-8
   PubMed Web of Science ®Google Scholar
• Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76–85. doi:10.1159/000350917
   PubMed Web of Science ®Google Scholar
• Muyanja DJ, Allen J, Vallarino L, et al. Kerosene lighting contributes to household air pollution in rural Uganda. Indoor Air. 2017;27(5):1022–1029. doi:10.1111/ina.12377
   PubMed Web of Science ®Google Scholar
• Kurmi OP, Semple S, Simkhada P, Smith WCS, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65(3):221–228. doi:10.1136/thx.2009.124644
   PubMed Web of Science ®Google Scholar